Declarations. Ethics approval: Not applicable. This manuscript is a narrative review of previously published literature and did not involve new studies in humans or animals performed by the authors. Declaration of generative AI and AI-assisted technologies in the manuscript preparation process: During preparation of this submission, the authors used OpenAI ChatGPT to assist with language editing and adaptation to journal formatting requirements. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the submitted manuscript. Consent to publish: Not applicable. Consent to participate: Not applicable. Competing interests: Lukasz Szarpak, Michal Pruc, Damian Swieczkowski, Bernard Rybczynski, and Aleksandra Pieta declare no conflicts of interest. Wiesław Jerzy Cubała reports grants from Acadia, Alkermes, Allergan, Angelini, Auspex Pharmaceuticals, Beckley Psytech, BMS, Celon, Cephalon, Compass Pathways, Cortexyme, Ferrier, Forest Laboratories, Gedeon Richter, GH Research, GW Pharmaceuticals, HMNC Brain Health, IntraCellular Therapies, Janssen, KCR, Lilly, Lundbeck, Minerva, MSD, NIH, Neumora, Novartis, Orion, Otsuka, Recognify Life Sciences, Sanofi, and Servier; honoraria from Adamed, Angelini, AstraZeneca, BMS, Celon, GH Research, GSK, Janssen, KRKA, Lekam, Lundbeck, Minerva, NeuroCog, Novartis, Orion, Pfizer, Polfa Tarchomin, Sanofi, Servier, and Zentiva; and advisory board participation for Angelini, Celon (ended 2021), Douglas Pharmaceuticals, GH Research, Janssen, MSD, Novartis, Polpharma, Sanofi, and Tasman Therapeutics.
PubMed
